AI + EXCLUSIVE DATA
AI analyzes funding data you can't access anywhere else
Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.
10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + real-time funding intelligence
✓Never see duplicates in your feed
INDUSTRY FIRST
Vaxess Technologies announced it raised $8.4 Million in an initial filing from an offering of $10 Million
Feb 26, 2025•6 months ago
Amount Raised
$8.4 Million
Company Information
Location
359 Allston Street
Cambridge, Massachusetts, United States
About
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.
Company News
(10 articles)Mon, 23 Jun 2025 07:00:00 GMT
Vaxess study highlights GLP-1 delivery with microarray patch - Drug Delivery Business
Wed, 09 Apr 2025 07:00:00 GMT
Vaxess raises $9M to support drug delivery patch, GLP-1 work - Drug Delivery Business
Tue, 26 Oct 2021 07:00:00 GMT
Vaxess Technologies Announces Grand Opening of GMP Manufacturing Facility - Business Wire
Wed, 13 Sep 2023 07:00:00 GMT
Vaxess raises $9m to accelerate mRNA vaccine patch development - Pharmaceutical Technology
Mon, 21 Aug 2023 07:00:00 GMT
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies - BioProcess International
Mon, 04 Dec 2023 08:00:00 GMT
Vaxess Technologies: Developing Vaccine Patches To Disrupt Multiple Billion-Dollar Markets - Pulse 2.0
Mon, 06 Mar 2017 08:00:00 GMT
Vaxess Technologies Receives Grants Totaling $6 Million to Develop Microneedle Vaccines for Polio, Measles, Rubella - PR Newswire
Tue, 09 Jan 2024 08:00:00 GMT
Vaxess device improves application of vaccine patches - BioWorld MedTech
Wed, 09 Apr 2025 07:00:00 GMT
Vaxess Raises $9M in Funding - FinSMEs
Wed, 27 Oct 2021 07:00:00 GMT
Vaxess Technologies opens GMP facility for vaccine patch clinical trials - Cleanroom Technology
FundzWatch™ Score
50
High Activity
5 total signals
Buyer Intent Analysis
Get personalized insights on buying likelihood
Related People
Sign in to view contact details
Sign in to view contact details